Cargando…
Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease
Despite widespread clinical use in the treatment of type 2 diabetes, the impact of sulfonylurea therapy on cardiovascular outcomes remains uncertain. Studies of naturally occurring genetic variation can be used to anticipate the expected clinical consequences of a pharmacological therapy. A common m...
Autores principales: | Emdin, Connor A., Klarin, Derek, Natarajan, Pradeep, Florez, Jose C., Kathiresan, Sekar, Khera, Amit V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521864/ https://www.ncbi.nlm.nih.gov/pubmed/28411266 http://dx.doi.org/10.2337/db17-0149 |
Ejemplares similares
-
A Polygenic Score for Type 2 Diabetes Risk Is Associated With Both the Acute and Sustained Response to Sulfonylureas
por: Li, Josephine H., et al.
Publicado: (2021) -
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors
por: Merino, Jordi, et al.
Publicado: (2020) -
Expression of Phosphofructokinase in Skeletal Muscle Is Influenced by Genetic Variation and Associated With Insulin Sensitivity
por: Keildson, Sarah, et al.
Publicado: (2014) -
Contribution of Common Genetic Variation to the Risk of Type 2 Diabetes in the Mexican Mestizo Population
por: Gamboa-Meléndez, Marco Alberto, et al.
Publicado: (2012) -
Deep Resequencing Unveils Genetic Architecture of ADIPOQ and Identifies a Novel Low-Frequency Variant Strongly Associated With Adiponectin Variation
por: Warren, Liling L., et al.
Publicado: (2012)